Saúde Pública em Pediatria

Causas globais, regionais e nacionais da mortalidade infantil (menores de 5 anos) em 2000-2019: análise sistemática atualizada com implicações para as Metas de Desenvolvimento Sustentável.

19 Nov, 2021 | 13:07h

Global, regional, and national causes of under-5 mortality in 2000–19: an updated systematic analysis with implications for the Sustainable Development Goals – The Lancet Child & Adolescent Health

 

Comentário no Twitter

Progress is still needed to improve child health and end preventable deaths among children <5 years

New cause-specific estimates of infant mortality for 2000-19 are explored in this Article by Jamie Perin and colleagues @JohnsHopkinsSPH, @LSHTM & @WHO https://t.co/QJEDAd5jYT pic.twitter.com/Wis0v8YSav

— The Lancet Child & Adolescent Health (@LancetChildAdol) November 18, 2021

Pneumonia remains #1 postneonatal killer for children <5. Most deaths occur in children who live in poverty or humanitarian settings, have poor access to quality care, are malnourished & unimmunised. Many health centres don’t have antibiotics or O2. It’s 2021 not the Middle Ages. https://t.co/P7EhDN9KJ2

— Fiona Russell (@Fiona_M_Russell) November 18, 2021

 

---

Revisão | Crianças com menos de 12 anos deveriam ser vacinadas contra COVID-19?

19 Nov, 2021 | 12:37h

Should children be vaccinated against COVID-19? – Archives of Disease in Childhood

 

Comentário do autor no Twitter (fio – clique para saber mais)

Should #children be vaccinated against #COVID19?

Our review outlines the points to consider in weighing up whether all healthy children under 12y should be vaccinated against COVID-19.https://t.co/JtoOr2TZoq#medpeds #IDTwitter #PaedsID #tweetiatrician #paediatrics

🧵1/n pic.twitter.com/g4UGu3pMsE

— Nigel Curtis (@nigeltwitt) November 6, 2021

 

---

Covid: no Reino Unido, crianças só devem tomar a dose da vacina 12 semanas depois de uma infecção.

19 Nov, 2021 | 12:35h

Covid: Children told to delay jab for 12 weeks after infection – BBC

Relatório original: Joint Committee on Vaccination and Immunisation (JCVI) advice on COVID-19 vaccination in people aged 16 to 17 years: 15 November 2021

---

Seguimento de longo prazo de estudo randomizado mostrou que bebês que receberam fórmula láctea enriquecida com suplementos ou nutrientes não apresentaram desempenho acadêmico melhor na adolescência.

17 Nov, 2021 | 12:43h

Comunicado de imprensa: Study finds no benefit of enriched formula milks on later academic performance – British Medical Journal

Estudo original: Effect of nutritionally modified infant formula on academic performance: linkage of seven dormant randomised controlled trials to national education data – The BMJ

Editorial: Enriched formula milks and academic performance in later childhood – The BMJ

 

Comentário no Twitter

Children who are given nutrient or supplement enriched formula milk as babies do not appear to have higher exam scores as adolescents than those fed with standard formula, suggests a study published @bmj_latest today https://t.co/QmE2QxRlXm @DrMaxVerfuerden

— BMJ (@bmj_company) November 11, 2021

 

---

#AHA21 – Estudo randomizado | Entre crianças e adolescentes submetidos a rastreamento ecocardiográfico e diagnosticados com doença cardíaca reumática latente, antibioticoprofilaxia secundária com penicilina G benzatina por 2 anos foi associada com redução da progressão ecocardiográfica (0,8 vs, 8,2% no grupo controle).

15 Nov, 2021 | 13:53h

Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentários:

Penicillin significantly reduces rheumatic heart disease progression in children – Murdoch Children’s Research Institute

Penicillin slows devastating impacts of rheumatic heart disease in children from Uganda – Children’s National Hospital

Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – American College of Cardiology

 

Comentários no Twitter

One of most important studies ever Rheumatic Heart Disease @NEJM https://t.co/U8FuNHLqCJ RCT evidence 2ry prophylaxis reduces progression latent RhD pic.twitter.com/UycTElr7QM

— Michael Marks (@dr_michaelmarks) November 13, 2021

Penicillin slowed the devastating impact of rheumatic heart disease among children in Uganda. Findings of a large-scale, randomized controlled trial were completed in Uganda. Group A strep underlies rheumatic heart disease. New England Journal of Medicine https://t.co/1PKFJ12FvC

— delthia ricks 🔬 (@DelthiaRicks) November 13, 2021

 

---

Mortalidade global, regional e nacional entre jovens de 10 a 24 anos, 1950–2019: uma análise sistemática do Global Burden of Disease Study 2019.

15 Nov, 2021 | 13:43h

Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019 – The Lancet

Comentários: Nearly two-thirds of those who died young in 2019 were male, research finds – The Guardian

 

Comentários no Twitter (fio – clique para saber mais)

✨🆕✨#GBDStudy 2019 analysis published by @TheLancet examined the global, regional, and national #mortality among young people aged 10-24 between 1950-2019, finding that mortality increased in 2019 with age globally🌎, particularly in males

Read here ⤵https://t.co/6gprq6gM0Z

— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) October 29, 2021

 

---

Mortes de crianças e jovens na Inglaterra após infecção por SARS-CoV-2 durante o 1º ano da pandemia – “Ao todo, 99,995% das crianças e jovens com teste positivo para SARS-CoV-2 sobreviveram.”

12 Nov, 2021 | 13:48h

Deaths in children and young people in England after SARS-CoV-2 infection during the first pandemic year – Nature

Conteúdo relacionado:

[Preprint] Study confirms children’s extremely low risk of death from Covid-19 – “99·995% of children and young people with a positive SARS-CoV-2 test survived”.

Study: Children and young people remain at low risk of COVID-19 mortality

 

Comentários no Twitter

Just published @NatureMedicine
An in-depth analysis of the 25 children who died from Covid in England during the 1st year of the pandemichttps://t.co/QK3gk1BXy5
Great that 99.995% of children w/ a positive test survived (not what is driving the need for 💉in kids) pic.twitter.com/moXKl8ysmA

— Eric Topol (@EricTopol) November 11, 2021

A clinical review of all pediatric deaths in England from March 2020 to February 2021 attributes 25 deaths to SARS-CoV-2 infection and identifies risk factors to guide interventions, according to a @NatureMedicine article. https://t.co/Bpjhf5sgow pic.twitter.com/v24Zf9CsXK

— Nature Portfolio (@NaturePortfolio) November 11, 2021

 

---

OMS, CDC | Progresso global contra o sarampo fica ameaçado em meio à pandemia de COVID-19.

12 Nov, 2021 | 13:36h

Comunicado de imprensa: Global progress against measles threatened amidst COVID-19 pandemic – World Health Organization

Relatório: Progress Toward Regional Measles Elimination — Worldwide, 2000–2020 – CDC Morbidity and Mortality Weekly Report

Comentário: Measles is a renewed global threat after 22 million babies missed their vaccines during the pandemic, CDC warns – CNN

 

Comentário no Twitter (fio – clique para saber mais)

While reported #measles cases have fallen compared to previous years, progress toward measles elimination continues to decline and the risk of outbreaks is mounting, according to a 🆕 report from @CDCgov & WHO.

👉 https://t.co/EjRVRexcGd pic.twitter.com/KnBU5RZn5i

— World Health Organization (WHO) (@WHO) November 10, 2021

 

---

Estudo randomizado | Vacina da Pfizer mostra 90,7% de eficácia na prevenção de Covid-19 em crianças de 5 a 11 anos de idade.

10 Nov, 2021 | 12:55h

Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age – New England Journal of Medicine

 

Comentário no Twitter

In this multi-phase trial, two 10-μg doses of the BNT162b2 vaccine administered 21 days apart were safe, immunogenic, and 90.7% effective against #COVID19 in 5-to-11-year-old children. #Covid19vaccine https://t.co/kuj2eI4YCE pic.twitter.com/BWEkYxn8a0

— NEJM (@NEJM) November 9, 2021

 

---

[Ainda não publicado] Farmacêutica Sinovac afirma que sua vacina contra Covid-19 é segura para crianças e mesmo bebês a partir dos 6 meses de vida.

8 Nov, 2021 | 12:45h

Chinese drug firm Sinovac says Covid-19 vaccine safe for children, babies as young as six months old; submits data to Hong Kong government – South China Morning Post

Conteúdos relacionados:

Randomized phase 1/2 trial: Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in children and adolescents aged 3–17 years.

Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.

---